1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6351 | MGCD-265 analog | MGCD-265 , Glesatinib | Apoptosis , VEGFR , c-Met/HGFR |
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively. |